You are here: Industry Insights > Market News > Dr Reddy’s announces arrival of first consignment of Sputnik V vaccine in India

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

Dr Reddy’s announces arrival of first consignment of Sputnik V vaccine in India

expresspharmaMay 06, 2021

Tag: Dr Reddy’s , Sputnik V vaccine , India

Favorites

Dr Reddy’s Laboratories announced that the first consignment of 150,000 doses of the Sputnik V vaccine has landed in Hyderabad from Russia.

The rollout of the consignment will be subject to the necessary clearances, which will be processed over the next few days.

“This initial quantity will be used across different channels as a pilot to line up our supply chain for the larger vaccination programme rollout,” informed a company statement.

Subsequent consignments will arrive in the next few weeks.

Previous:Cell therapy for solid tumors may get approval by 2022: GlobalData

Next:More than 78 lakh COVID vaccine doses still available with states and UTs: Centre

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Dr Reddy’s announces arrival of first consignment of Sputnik V vaccine in India | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

Dr Reddy’s announces arrival of first consignment of Sputnik V vaccine in India

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may like
More>>

Dr Reddy’s announces arrival of first consignment of Sputnik V vaccine in India

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>